Inflammation and central nervous system Lyme disease

Aalto, 2007, Brain magnetic resonance imaging does not contribute to the diagnosis of chronic neuroborreliosis, Acta Radiol., 48, 755, 10.1080/02841850701367903 Aberer, 1989, Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue, Ann. Neurol., 26, 732, 10.1002/ana.410260608 Ackermann, 1984, Tick-borne meningopolyneuritis (Garin–Bujadoux, Bannwarth), Yale J. Biol. Med., 57, 485 Ackermann, 1985, Progressive Borrelia encephalomyelitis. Chronic manifestation of erythema chronicum migrans disease of the nervous system., Dtsch. Med. Wochenschr., 110, 1039, 10.1055/s-2008-1068956 Alaedini, 2005, Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissue, J. Neuroimmunol., 159, 192, 10.1016/j.jneuroim.2004.10.014 Alitalo, 2005, Expression of complement factor H binding immunoevasion proteins in Borrelia garinii isolated from patients with neuroborreliosis, Eur. J. Immunol., 35, 3043, 10.1002/eji.200526354 Allal, 1986, Borrelia isolated from cerebrospinal fluid in a French case of Lyme disease, Ann. Rheum. Dis., 45, 789, 10.1136/ard.45.9.789-b Anisman, 2003, Sensitization associated with stressors and cytokine treatments, Brain Behav. Immun., 17, 86, 10.1016/S0889-1591(02)00100-9 Anisman, 2008, Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders, Prog. Neurobiol., 85, 1, 10.1016/j.pneurobio.2008.01.004 Baig, 1991, Cells secreting antibodies to myelin basic protein in cerebrospinal fluid of patients with Lyme neuroborreliosis, Neurology, 41, 581, 10.1212/WNL.41.4.581 Banati, 2002, Visualising microglial activation in vivo, Glia, 40, 206, 10.1002/glia.10144 Banati, 2000, The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity, Brain, 123, 2321, 10.1093/brain/123.11.2321 Bernardino, 2008, Toll-like receptors: insights into their possible role in the pathogenesis of Lyme neuroborreliosis, Infect. Immun., 76, 4385, 10.1128/IAI.00394-08 Bernardino, 2009, The antibiotics doxycycline and minocycline inhibit the inflammatory responses to the Lyme disease spirochete Borrelia burgdorferi, J. Infect. Dis., 199, 1379, 10.1086/597807 Bertrand, 1999, Central nervous system infection caused by Borrelia burgdorferi. Clinico-pathological correlation of three post-mortem cases, Folia Neuropathol., 37, 43 Brorson, 2001, Association between multiple sclerosis and cystic structures in cerebrospinal fluid, Infection, 29, 315, 10.1007/s15010-001-9144-y Burgdorfer, 1982, Lyme disease—a tick-borne spirochetosis?, Science, 216, 1317, 10.1126/science.7043737 Cadavid, 2006, The mammalian host response to borrelia infection, Wien. Klin. Wochenschr., 118, 653, 10.1007/s00508-006-0692-0 Cadavid, 2000, Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme disease, Lab. Invest., 80, 1043, 10.1038/labinvest.3780109 Cagnin, 2007, Positron emission tomography imaging of neuroinflammation, Neurotherapeutics, 4, 443, 10.1016/j.nurt.2007.04.006 Camponovo, 1986, Neuropathy of vasculitic origin in a case of Garin–Boujadoux–Bannwarth syndrome with positive borrelia antibody response, J. Neurol., 233, 69, 10.1007/BF00313849 Capuron, 2003, Cytokines and depression: the need for a new paradigm, Brain. Behav. Immun., 17, S119, 10.1016/S0889-1591(02)00078-8 Carlson, 2006, The pathogenic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis, J. Neuroimmunol., 174, 21, 10.1016/j.jneuroim.2006.01.008 Casjens, 2000, A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi, Mol. Microbiol., 35, 490, 10.1046/j.1365-2958.2000.01698.x Cepok, 2003, The immune response at onset and during recovery from Borrelia burgdorferi meningoradiculitis, Arch. Neurol., 60, 849, 10.1001/archneur.60.6.849 Cepok, 2005, Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis, Brain, 128, 1667, 10.1093/brain/awh486 Cerar, 2008, Validation of cultivation and PCR methods for diagnosis of Lyme neuroborreliosis, J. Clin. Microbiol., 46, 3375, 10.1128/JCM.00410-08 Cernak, 2001, Activation of cyclooxygenase-2 contributes to motor and cognitive dysfunction following diffuse traumatic brain injury in rats, Clin. Exp. Pharmacol. Physiol., 28, 922, 10.1046/j.1440-1681.2001.03549.x Chmielewska-Badora, 2000, Lyme borreliosis and multiple sclerosis: any connection? A seroepidemic study, Ann. Agric. Environ. Med., 7, 141 Comstock, 1989, Penetration of endothelial cell monolayers by Borrelia burgdorferi, Infect. Immun., 57, 1626, 10.1128/iai.57.5.1626-1628.1989 Coulter, 2005, Two-year evaluation of Borrelia burgdorferi culture and supplemental tests for definitive diagnosis of Lyme disease, J. Clin. Microbiol., 43, 5080, 10.1128/JCM.43.10.5080-5084.2005 Coyle, 1993, Detection of Borrelia burgdorferi antigens in cerebrospinal fluid, Neurology, 43, 1093, 10.1212/WNL.43.6.1093 Coyle, 1993, Significance of reactive Lyme serology in multiple sclerosis, Ann. Neurol., 34, 745, 10.1002/ana.410340521 Dantzer, 2001, Cytokine-induced sickness behavior: where do we stand?, Brain Behav. Immun., 15, 7, 10.1006/brbi.2000.0613 Dantzer, 2008, From inflammation to sickness and depression: when the immune system subjugates the brain, Nat. Rev., 9, 46, 10.1038/nrn2297 Dattwyler, 1988, Treatment of late Lyme borreliosis—randomised comparison of ceftriaxone and penicillin, Lancet, 1, 1191, 10.1016/S0140-6736(88)92011-9 Dickson, 1993, Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease, Glia, 7, 75, 10.1002/glia.440070113 Duray, 1989, Histopathology of clinical phases of human Lyme disease, Rheum. Dis. Clin. North. Am., 15, 691, 10.1016/S0889-857X(21)01023-1 Duray, 1988, Clinical pathologic correlations of Lyme disease by stage, Ann. N. Y. Acad. Sci., 539, 65, 10.1111/j.1749-6632.1988.tb31839.x Fallon, 1997, Functional brain imaging and neuropsychological testing in Lyme disease, Clin. Infect. Dis., 25, S57, 10.1086/516175 Fallon, 1994, Lyme disease: a neuropsychiatric illness, Am. J. Psychiatry, 151, 1571, 10.1176/ajp.151.11.1571 Fallon, 2008, A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy, Neurology, 70, 992, 10.1212/01.WNL.0000284604.61160.2d Fallon, 2009, Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy, Arch. Gen. Psychiatry, 66, 554, 10.1001/archgenpsychiatry.2009.29 Fikrig, 1993, Serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to a neuroblastoma cell line, Proc. Natl. Acad. Sci. U. S. A., 90, 183, 10.1073/pnas.90.1.183 Fraser, 1997, Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi, Nature, 390, 580, 10.1038/37551 Friedman, 2005, Interactions of interleukin-1 with neurotrophic factors in the central nervous system: beneficial or detrimental?, Mol. Neurobiol., 32, 133, 10.1385/MN:32:2:133 Garcia-Monco, 1997, Mechanisms of injury in Lyme neuroborreliosis, Semin. Neurol., 17, 57, 10.1055/s-2008-1040914 Garcia-Monco, 1988, Antibodies to myelin basic protein in Lyme disease, J. Infect. Dis., 158, 667, 10.1093/infdis/158.3.667 Garcia-Monco, 1990, Lyme borreliosis: neurologic manifestations, Neurologia, 5, 315 Grab, 2005, Borrelia burgdorferi, host-derived proteases, and the blood–brain barrier, Infect. Immun., 73, 1014, 10.1128/IAI.73.2.1014-1022.2005 Grusell, 2002, Increased expression of the Th1-inducing cytokines interleukin-12 and interleukin-18 in cerebrospinal fluid but not in sera from patients with Lyme neuroborreliosis, J. Neuroimmunol., 131, 173, 10.1016/S0165-5728(02)00255-2 Halperin, 1991, North American Lyme neuroborreliosis, Scand. J. Infect. Dis. Suppl., 77, 74 Halperin, 1992, Neuroactive kynurenines in Lyme borreliosis, Neurology, 42, 43, 10.1212/WNL.42.1.43 Halperin, 1989, Lyme neuroborreliosis: central nervous system manifestations, Neurology, 39, 753, 10.1212/WNL.39.6.753 Hansen, 1992, The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985–1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production, Brain, 115, 399, 10.1093/brain/115.2.399 Hassett, 2008, Role of psychiatric comorbidity in chronic Lyme disease, Arthritis Rheum., 59, 1742, 10.1002/art.24314 Haupl, 1997, Activation of monocytes by three OspA vaccine candidates: lipoprotein OspA is a potent stimulator of monokines, FEMS Immunol. Med. Microbiol., 19, 15, 10.1016/S0928-8244(97)00046-1 Heinrich, 2003, Cerebral vasculitis as the only manifestation of Borrelia burgdorferi infection in a 17-year-old patient with basal ganglia infarction, Eur. Neurol., 50, 109, 10.1159/000072510 Hildenbrand, 2009, Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis, AJNR Am. J. Neuroradiol., 30, 1079, 10.3174/ajnr.A1579 Kan, 1998, Pseudotumor cerebri in Lyme disease: a case report and literature review, Pediatr. Neurol., 18, 439, 10.1016/S0887-8994(97)00215-4 Kaplan, 1997, Lyme encephalopathy: a neuropsychological perspective, Semin. Neurol., 17, 31, 10.1055/s-2008-1040910 Katsuki, 1990, Interleukin-1 inhibits long-term potentiation in the CA3 region of mouse hippocampal slices, Eur. J. Pharmacol., 181, 323, 10.1016/0014-2999(90)90099-R Katz, A.M., (2009). Diminished Epidermal Nerve Fiber Density in Patients With Antibodies to Outer Surface Protein A (OspA) of B. burgdorferi Improves with Intravenous Immunoglobulin Therapy. Abstract P02.021, American Academy of Neurology, 61st Annual meeting. Keil, 1997, Vasculitis course of neuroborreliosis with thalamic infarct, Nervenarzt, 68, 339, 10.1007/s001150050133 Keilp, 2006, WAIS-III and WMS-III performance in chronic Lyme disease, J. Int. Neuropsychol. Soc., 12, 119, 10.1017/S1355617706060231 Kindstrand, 2000, Polyneuropathy in late Lyme borreliosis - a clinical, neurophysiological and morphological description, Acta Neurol. Scand., 101, 47, 10.1034/j.1600-0404.2000.00019.x Kraiczy, 2002, Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody, Int. J. Med. Microbiol., 291, 141, 10.1016/S1438-4221(02)80027-3 Krause, 1996, Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness, JAMA, 275, 1657, 10.1001/jama.1996.03530450047031 Latov, 2004, Neuropathy and cognitive impairment following vaccination with the OspA protein of Borrelia burgdorferi, J. Peripher. Nerv. Syst., 9, 165, 10.1111/j.1085-9489.2004.09306.x Liegner, 1998, Lyme Disease and the Clinical Spectrum of antibiotic-responsive meningoencephalomyelitides, J. Spirochetal. Tick Borne Dis., 4, 62 Livengood, 2006, Invasion of human neuronal and glial cells by an infectious strain of Borrelia burgdorferi, Microbes Infect., 8, 2832, 10.1016/j.micinf.2006.08.014 Ljostad, 2008, CSF B–lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis, J. Neurol., 255, 732, 10.1007/s00415-008-0785-y Logigian, 1997, Reversible cerebral hypoperfusion in Lyme encephalopathy, Neurology, 49, 1661, 10.1212/WNL.49.6.1661 Luft, 1992, Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection, JAMA, 267, 1364, 10.1001/jama.1992.03480100070033 Ma, 2005, Up-regulation of interleukin-6 induced by prostaglandin E from invading macrophages following nerve injury: an in vivo and in vitro study, J. Neurochem., 93, 664, 10.1111/j.1471-4159.2005.03050.x Maeda, 2004, Novel peripheral benzodiazepine receptor ligand 11C- DAA1106 for PET: an imaging tool for glial cells in the brain, Synapse, 52, 283, 10.1002/syn.20027 Maraspin, 2002, Cerebrospinal fluid findings in adult patients with multiple erythema migrans, Wien. Klin. Wochenschr., 114, 505 Martin, 1988, Borrelia burgdorferi-specific and autoreactive T-cell lines from cerebrospinal fluid in Lyme radiculomyelitis, Ann. Neurol., 24, 509, 10.1002/ana.410240406 Martin, 2001, Molecular mimicry and antigen-specific T cell responses in multiple sclerosis and chronic CNS Lyme disease, J. Autoimmun., 16, 187, 10.1006/jaut.2000.0501 May, 1990, Stroke in neuroborreliosis, Stroke, 21, 1232, 10.1161/01.STR.21.8.1232 McAfoose, 2009, Evidence for a cytokine model of cognitive function, Neurosci. Biobehav. Rev., 33, 355, 10.1016/j.neubiorev.2008.10.005 Meier, 1988, Vasculitic neuropathy in the Garin–Bujadoux–Bannwarth syndrome. A contribution to the understanding of the pathology and pathogenesis of the neurological complications in Lyme borreliosis, Dtsch. Med. Wochenschr., 113, 135, 10.1055/s-2008-1067607 Meurers, 1990, Histopathological findings in the central and peripheral nervous systems in neuroborreliosis. A report of three cases, J. Neurol., 237, 113, 10.1007/BF00314674 Millner, 1991, Lyme borreliosis of central nervous system (CNS) in children: a diagnostic challenge, Infection, 19, 273, 10.1007/BF01644966 Morrison, 1997, Borrelia burgdorferi outer surface protein A (OspA) activates and primes human neutrophils, J. Immunol., 158, 4838, 10.4049/jimmunol.158.10.4838 Narayan, 2005, The nervous system as ectopic germinal center: CXCL13 and IgG in Lyme neuroborreliosis, Ann. Neurol., 57, 813, 10.1002/ana.20486 Nawa, 2000, Cytokine and growth factor involvement in schizophrenia-support for the developmental model, Mol. Psychiatry, 5, 594, 10.1038/sj.mp.4000730 Neophytides, 1997, Subacute cerebellitis in Lyme disease, Int. J. Clin. Pract., 51, 523, 10.1111/j.1742-1241.1997.tb11541.x Norgard, 1996, Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B, Infect. Immun., 64, 3845, 10.1128/iai.64.9.3845-3852.1996 Norris, 2006, Antigenic variation with a twist—the Borrelia story, Mol. Microbiol., 60, 1319, 10.1111/j.1365-2958.2006.05204.x Oksi, 1996, Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature, Brain, 119, 2143, 10.1093/brain/119.6.2143 Okuyama, 1999, Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106, Life Sci., 64, 1455, 10.1016/S0024-3205(99)00079-X Pachner, 1988, Borrelia burgdorferi in the nervous system: the new great imitator, Ann. N. Y. Acad. Sci., 539, 56, 10.1111/j.1749-6632.1988.tb31838.x Pachner, 1985, The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis, Neurology, 35, 47, 10.1212/WNL.35.1.47 Pachner, 2007, Lyme neuroborreliosis: infection, immunity, and inflammation, Lancet Neurol., 6, 544, 10.1016/S1474-4422(07)70128-X Pachner, 1994, A rabbit model of Lyme neuroborreliosis: characterization by PCR, serology, and sequencing of the OspA gene from the brain, Neurology, 44, 1938, 10.1212/WNL.44.10.1938 Pachner, 1995, Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human disease, Neurology, 45, 165, 10.1212/WNL.45.1.165 Pachner, 1997, Interleukin-6 is expressed at high levels in the CNS in Lyme neuroborreliosis, Neurology, 49, 147, 10.1212/WNL.49.1.147 Pachner, 2001, Lyme borreliosis in rhesus macaques: effects of corticosteroids on spirochetal load and isotype switching of anti-Borrelia burgdorferi antibody, Clin. Diagn. Lab. Immunol., 8, 225, 10.1128/CDLI.8.2.225-232.2001 Pachner, 2001, The rhesus model of Lyme neuroborreliosis, Immunol. Rev., 183, 186, 10.1034/j.1600-065x.2001.1830115.x Pfister, 1984, The spirochetal etiology of lymphocytic meningoradiculitis of Bannwarth (Bannwarth's syndrome), J. Neurol., 231, 141, 10.1007/BF00313682 Ramesh, 2005, Pathogenesis of Lyme neuroborreliosis: mitogen-activated protein kinases Erk1, Erk2, and p38 in the response of astrocytes to Borrelia burgdorferi lipoproteins, Neurosci. Lett., 384, 112, 10.1016/j.neulet.2005.04.069 Ramesh, 2003, Pathogenesis of Lyme neuroborreliosis: Borrelia burgdorferi lipoproteins induce both proliferation and apoptosis in rhesus monkey astrocytes, Eur. J. Immunol., 33, 2539, 10.1002/eji.200323872 Ramesh, 2008, Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis, Am. J. Pathol., 173, 1415, 10.2353/ajpath.2008.080483 Ramesh, 2009, Possible role of glial cells in the onset and progression of Lyme neuroborreliosis, J. Neuroinflammation, 6, 23, 10.1186/1742-2094-6-23 Rasley, 2002, Borrelia burgdorferi induces inflammatory mediator production by murine microglia, J. Neuroimmunol., 130, 22, 10.1016/S0165-5728(02)00187-X Reik, 1979, Neurologic abnormalities of Lyme disease, Med. (Baltimore)., 58, 281, 10.1097/00005792-197907000-00001 Rumbaugh, 2007, Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins, J. Neurovirology, 13, 168, 10.1080/13550280601178218 Rupprecht, 2005, The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis, Neurology, 65, 448, 10.1212/01.wnl.0000171349.06645.79 Rupprecht, 2006, Cytokine CXCL13–a possible early CSF marker for neuroborreliosis, Nervenarzt, 77, 470, 10.1007/s00115-005-2021-7 Rupprecht, 2008, Autoimmune-mediated polyneuropathy triggered by borrelial infection?, Muscle Nerve, 37, 781, 10.1002/mus.20929 Rupprecht, 2008, The pathogenesis of Lyme neuroborreliosis: from infection to inflammation, Mol. Med., 14, 205, 10.2119/2007-00091.Rupprecht Schmiedel, 2004, Cerebral vasculitis with multiple infarcts caused by Lyme disease, Cerebrovasc. Dis., 17, 79, 10.1159/000073904 Schutzer, 1997, Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease, J. Clin. Invest., 100, 763, 10.1172/JCI119589 Schwan, 2000, Temporal changes in outer surface proteins A and C of the Lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice, J. Clin. Microbiol., 38, 382, 10.1128/JCM.38.1.382-388.2000 Sellati, 1995, Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro, Infect. Immun., 63, 4439, 10.1128/iai.63.11.4439-4447.1995 Sigal, 1993, Cross-reactivity between Borrelia burgdorferi flagellin and a human axonal 64,000 molecular weight protein, J. Infect. Dis., 167, 1372, 10.1093/infdis/167.6.1372 Sigal, 1988, Lyme disease patients' serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens, Neurology, 38, 1439, 10.1212/WNL.38.9.1439 Sigal, 1997, A monoclonal antibody to Borrelia burgdorferi flagellin modifies neuroblastoma cell neuritogenesis in vitro: a possible role for autoimmunity in the neuropathy of Lyme disease, Infect. Immun., 65, 1722, 10.1128/iai.65.5.1722-1728.1997 Straubinger, 2000, Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: an experimental study, J. Infect. Dis., 181, 1069, 10.1086/315340 Strle, 2006, Comparison of findings for patients with Borrelia garinii and Borrelia afzelii isolated from cerebrospinal fluid, Clin. Infect. Dis., 43, 704, 10.1086/506936 Strother, 2007, Infection of mice with Lyme disease spirochetes constitutively producing outer surface proteins a and B, Infect. Immun., 75, 2786, 10.1128/IAI.01307-06 Suchanek, 1986, Anti-myelin antibodies in cerebrospinal fluid and serum of patients with meningopolyneuritis Garin–Bujadoux–Bannwarth and other neurological diseases, Zentralbl. Bakteriol. Mikrobiol. Hyg. A., 263, 160 Szczepanski, 1991, Lyme borreliosis: host responses to Borrelia burgdorferi, Microbiol. Rev., 55, 21, 10.1128/mr.55.1.21-34.1991 Teeling, 2009, Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms, Neuroscience, 158, 1062, 10.1016/j.neuroscience.2008.07.031 Tilders, 1999, Cross-sensitization between immune and non-immune stressors. A role in the etiology of depression?, Adv. Exp. Med. Biol., 461, 179, 10.1007/978-0-585-37970-8_11 Topakian, 2007, Unexplained cerebral vasculitis and stroke: keep Lyme neuroborreliosis in mind, Lancet Neurol., 6, 756, 10.1016/S1474-4422(07)70203-X Topakian, 2008, Cerebral vasculitis and stroke in Lyme neuroborreliosis. Two case reports and review of current knowledge, Cerebrovasc. Dis., 26, 455, 10.1159/000155982 Uldry, 1987, Cerebral angiopathy and recurrent strokes following Borrelia burgdorferi infection, J. Neurol. Neurosurg. Psychiatry, 50, 1703, 10.1136/jnnp.50.12.1703 Vaalburg, 2005, P-glycoprotein activity and biological response, Toxicol. Appl. Pharmacol., 207, 257, 10.1016/j.taap.2005.03.027 Veenendaal-Hilbers, 1988, Basal meningovasculitis and occlusion of the basilar artery in two cases of Borrelia burgdorferi infection, Neurology, 38, 1317, 10.1212/WNL.38.8.1317 Weigelt, 1992, Sequence homology between spirochaete flagellin and human myelin basic protein, Immunol. Today, 13, 279, 10.1016/0167-5699(92)90012-V Weis, 1994, Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification, Infect. Immun., 62, 4632, 10.1128/iai.62.10.4632-4636.1994 Weller, 1991, Cerebrospinal fluid interleukins, immunoglobulins, and fibronectin in neuroborreliosis, Arch. Neurol., 48, 837, 10.1001/archneur.1991.00530200079022 Widhe, 2002, Cytokines in Lyme borreliosis: lack of early tumour necrosis factor-alpha and transforming growth factor-beta1 responses are associated with chronic neuroborreliosis, Immunology, 107, 46, 10.1046/j.1365-2567.2002.01500.x Widhe, 2004, Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome, J. Infect. Dis., 189, 1881, 10.1086/382893 Widhe, 2005, Up-regulation of Borrelia-specific IL-4- and IFN-gamma-secreting cells in cerebrospinal fluid from children with Lyme neuroborreliosis, Int. Immunol., 17, 1283, 10.1093/intimm/dxh304 Wilke, 2000, Primarily chronic and cerebrovascular course of Lyme neuroborreliosis: case reports and literature review, Arch. Dis. Child., 83, 67, 10.1136/adc.83.1.67 Wilske, 2007, Microbiological and serological diagnosis of Lyme borreliosis, FEMS Immunol. Med. Microbiol., 49, 13, 10.1111/j.1574-695X.2006.00139.x Wormser, 2001, Yield of large-volume blood cultures in patients with early Lyme disease, J. Infect. Dis., 184, 1070, 10.1086/323424 Xu, 2008, Essential protective role attributed to the surface lipoproteins of Borrelia burgdorferi against innate defences, Mol. Microbiol., 69, 15, 10.1111/j.1365-2958.2008.06264.x Zeise, 1992, Interleukin-1 increases synaptic inhibition in rat hippocampal pyramidal neurons in vitro, Regul. Pept., 39, 1, 10.1016/0167-0115(92)90002-C